메뉴 건너뛰기




Volumn 58, Issue 25, 2011, Pages 2654-2661

High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: A multiethnic case-control study

Author keywords

high sensitivity C reactive protein; myocardial infarction; ST segment elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 82955207677     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.08.055     Document Type: Article
Times cited : (67)

References (19)
  • 1
    • 4444382796 scopus 로고    scopus 로고
    • Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study
    • DOI 10.1016/S0140-6736(04)17018-9, PII S0140673604170189
    • S. Yusuf, S. Hawken, S. Ounpuu INTERHEART Study Investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 2004 937 952 (Pubitemid 39208455)
    • (2004) Lancet , vol.364 , Issue.9438 , pp. 937-952
    • Yusuf, P.S.1    Hawken, S.2    Ounpuu, S.3    Dans, T.4    Avezum, A.5    Lanas, F.6    McQueen, M.7    Budaj, A.8    Pais, P.9    Varigos, J.10    Lisheng, L.11
  • 2
    • 22544476866 scopus 로고    scopus 로고
    • Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: A substudy of the COMMA trial
    • DOI 10.1093/eurheartj/ehi292
    • P. Theroux, P.W. Armstrong, and K.W. Mahaffey Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial Eur Heart J 19 2005 1964 1970 (Pubitemid 41435718)
    • (2005) European Heart Journal , vol.26 , Issue.19 , pp. 1964-1970
    • Theroux, P.1    Armstrong, P.W.2    Mahaffey, K.W.3    Hochman, J.S.4    Malloy, K.J.5    Rollins, S.6    Nicolau, J.C.7    Lavoie, J.8    The, M.L.9    Burchenal, J.10    Granger, C.B.11
  • 3
    • 0035824178 scopus 로고    scopus 로고
    • Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: Effects of an early invasive or noninvasive strategy
    • E. Lindmark, E. Diderholm, L. Wallentin, and A. Siegbahn Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy JAMA 286 2001 2107 2113 (Pubitemid 34041595)
    • (2001) Journal of the American Medical Association , vol.286 , Issue.17 , pp. 2107-2113
    • Lindmark, E.1    Diderholm, E.2    Wallentin, L.3    Siegbahn, A.4
  • 5
    • 33847109797 scopus 로고    scopus 로고
    • Use and misuse of the receiver operating characteristic curve in risk prediction
    • DOI 10.1161/CIRCULATIONAHA.106.672402, PII 0000301720070220000018
    • N.R. Cook Use and misuse of the receiver operating characteristic curve in risk prediction Circulation 115 2007 928 935 (Pubitemid 46294733)
    • (2007) Circulation , vol.115 , Issue.7 , pp. 928-935
    • Cook, N.R.1
  • 6
    • 56749106312 scopus 로고    scopus 로고
    • Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
    • JUPITER Study Group
    • P.M. Ridker, E. Danielson, F.A. Fonseca JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
    • (2008) N Engl J Med , vol.359 , pp. 2195-2207
    • Ridker, P.M.1    Danielson, E.2    Fonseca, F.A.3
  • 7
    • 67949124665 scopus 로고    scopus 로고
    • Testing the inflammatory hypothesis of atherothrombosis: Scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
    • P.M. Ridker Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT) J Thromb Haemost Suppl 1 2009 332 339
    • (2009) J Thromb Haemost , Issue.SUPPL. 1 , pp. 332-339
    • Ridker, P.M.1
  • 8
    • 0033535812 scopus 로고    scopus 로고
    • Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations
    • DOI 10.1016/S0140-6736(99)04021-0
    • H. Tunstall-Pedoe, K. Kuulasmaa, M. Mahonen, H. Tolonen, E. Ruokokoski, and P. Amouyel Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations Monitoring trends and determinants in cardiovascular disease Lancet 353 1999 1547 1557 (Pubitemid 29219203)
    • (1999) Lancet , vol.353 , Issue.9164 , pp. 1547-1557
    • Tunstall-Pedoe, H.1    Kuulasmaa, K.2    Mahonen, M.3    Tolonen, H.4    Ruokokoski, E.5    Amouyel, P.6
  • 9
    • 0020072450 scopus 로고
    • Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction
    • F.C. de Beer, C.R. Hind, K.M. Fox, R.M. Allan, A. Maseri, and M.B. Pepys Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction Br Heart J 47 1982 239 243 (Pubitemid 12179920)
    • (1982) British Heart Journal , vol.47 , Issue.3 , pp. 239-243
    • De Beer, F.C.1    Hind, C.R.K.2    Fox, K.M.3
  • 10
    • 0030956673 scopus 로고    scopus 로고
    • Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
    • DOI 10.1056/NEJM199704033361401
    • P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979 (Pubitemid 27152782)
    • (1997) New England Journal of Medicine , vol.336 , Issue.14 , pp. 973-979
    • Ridker, P.M.1    Cushman, M.2    Stampfer, M.J.3    Tracy, R.P.4    Hennekens, C.H.5
  • 11
    • 43249118045 scopus 로고    scopus 로고
    • Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review
    • J. Danesh, S. Kaptoge, and A.G. Mann Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review PLoS Med 5 2008 e78
    • (2008) PLoS Med , vol.5 , pp. 78
    • Danesh, J.1    Kaptoge, S.2    Mann, A.G.3
  • 13
    • 85101729518 scopus 로고    scopus 로고
    • High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): A prospective study
    • Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 200;358:202-633.
    • Lancet , vol.200 , Issue.358 , pp. 202-633
    • Walldius, G.1    Jungner, I.2    Holme, I.3    Aastveit, A.H.4    Kolar, W.5    Steiner, E.6
  • 14
    • 51649092992 scopus 로고    scopus 로고
    • C-reactive protein and coronary heart disease: A critical review
    • J.P. Casas, T. Shah, A.D. Hingorani, J. Danesh, and M.B. Pepys C-reactive protein and coronary heart disease: a critical review J Intern Med 264 2008 295 314
    • (2008) J Intern Med , vol.264 , pp. 295-314
    • Casas, J.P.1    Shah, T.2    Hingorani, A.D.3    Danesh, J.4    Pepys, M.B.5
  • 15
    • 61549120401 scopus 로고    scopus 로고
    • Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: Results from PROVE IT-TIMI 22
    • K.K. Ray, C.P. Cannon, R. Cairns, D.A. Morrow, P.M. Ridker, and E. Braunwald Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22 Arterioscler Thromb Vasc Biol 29 2009 424 430
    • (2009) Arterioscler Thromb Vasc Biol , vol.29 , pp. 424-430
    • Ray, K.K.1    Cannon, C.P.2    Cairns, R.3    Morrow, D.A.4    Ridker, P.M.5    Braunwald, E.6
  • 16
    • 56749106312 scopus 로고    scopus 로고
    • Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
    • JUPITER Study Group 219520
    • P.M. Ridker, E. Danielson, F.A. Fonseca JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 219520
    • (2008) N Engl J Med , vol.359
    • Ridker, P.M.1    Danielson, E.2    Fonseca, F.A.3
  • 18
    • 61949199214 scopus 로고    scopus 로고
    • States, rates and traits: Prognosis research and chronic stable angina
    • H. Hemingway States, rates and traits: prognosis research and chronic stable angina Heart 95 2009 439 440
    • (2009) Heart , vol.95 , pp. 439-440
    • Hemingway, H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.